CGEN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $2.31
Market Cap $218M
P/E 6.1
EPS $0.38
Revenue $73M
ROE 44.8%
52W Range $1–$3

CGEN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$73M
2016-12-31 → 2025-12-31
EPS$0.38
2016-12-31 → 2025-12-31
Free Cash Flow$31M
2016-12-31 → 2025-12-31
Net margin48.6%
2016-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend CGEN 5Y avg Peer Median Verdict
P/E 6.15Y avg ≈-5.5 ≈-5.5 · ·
P/S 3.05Y avg ≈16.5 ≈16.5 · ·
P/B 2.15Y avg ≈2.2 ≈2.2 · ·
Price / FCF 7.05Y avg ≈-3.1 ≈-3.1 · ·
Price / Cash Flow 6.95Y avg ≈-3.1 ≈-3.1 · ·
Price / Tangible Book 2.15Y avg ≈2.2 ≈2.2 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 173.4%
Next Report Nov 09, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 11, 2026 $-0.07 $-0.08 14.2%
March 31, 2026 May 18, 2026 $-0.08 $-0.07 -8.1%
Dec. 31, 2025 $0.60 $0.05 1076.5%
Sept. 30, 2025 $-0.07 $-0.09 20.8%
June 30, 2025 $-0.08 $-0.07 -20.7%
March 31, 2025 $-0.08 $-0.06 -42.6%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 16
Metric Trend 202520242023202220212020201920182017201620152014
Revenue $73M$28M$33M$8M$6M$2M·$18M·$712.0K$9M$12M
Cost of Revenue $9M$8M$2M$975.0K$680.0K$60.0K·$1M·$223.0K$2M$3M
Gross Profit $64M$20M$31M$7M$5M$2M·$17M·$489.0K$8M$9M
R&D Expense $23M$25M$34M$31M$29M$23M$20M$30M$29M$25M$21M$15M
SG&A Expense $9M$9M$10M$10M$11M$10M$8M$8M$8M$7M$6M$5M
Operating Expenses $32M$35M$44M$42M$40M$33M$29M$40M$37M$33M$29M$21M
Operating Income $31M$-15M$-13M$-35M$-35M$-31M$-29M$-23M$-37M$-33M$-21M$-12M
Interest Income $4M$3M$3M$1M$894.0K$2M$935.0K$643.0K$523.0K$728.0K$815.0K$346.0K
Pretax Income $35M$-10M$-10M$-34M$-34M$-30M$-28M$-23M$-37M$-31M$-20M$-11M
Income Tax $54.0K$5M$9M$58.0K$0$0$-722.0K··$20.0K$390.0K$360.0K
Net Income $35M$-14M$-19M$-34M$-34M$-30M$-27M$-23M$-37M$-32M$-20M$-11M
EPS (Basic) $0.38$-0.16$-0.21$-0.39$-0.41$-0.37$-0.43$-0.41$-0.72$-0.62$-0.40$-0.23
EPS (Diluted) $0.38$-0.16$-0.21$-0.39$-0.41$-0.37$-0.43$-0.41$-0.72$-0.62$-0.40$-0.26
Shares (Basic) 93,425,34189,528,03187,633,29886,555,62884,203,97179,591,18763,636,67355,277,42851,179,69450,855,90850,437,04047,808,855
Shares (Diluted) 93,815,08389,528,03187,633,29886,555,62884,203,97179,591,18763,636,67355,277,42851,179,69450,855,90850,437,04048,387,063
EBITDA $31M$-15M$-13M$-35M$-35M$-31M$-29M$-23M$-37M$-33M$-21M$-12M
Balance Sheet 20
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents $91M$18M$14M$11M$8M$7M$9M$6M$25M$10M$11M$26M
Short-term Investments $9M$24M$12M$0······$426.0K$1M
Receivables ·$0$61M$0·$2M····$8M·
Prepaid Expense $2M$3M$3M$2M$5M$3M$1M$903.0K$741.0K$1M$1M$716.0K
Other Current Assets $144.0K$142.0K$226.0K$232.0K$131.0K$122.0K$306.0K$58.0K··$114.0K$16.0K
Current Assets $148M$106M$115M$86M$123M$129M$45M$47M$31M$63M$91M$75M
PP&E (Net) $681.0K$852.0K$1M$2M$2M$2M$2M$3M$5M$6M$6M$3M
PP&E (Gross) $7M$7M$7M$8M$8M$7M$7M$10M$10M$9M$8M$12M
Accum. Depreciation $6M$6M$5M$6M$6M$5M$5M$6M$5M$3M$2M$9M
Total Assets $157M$115M$121M$94M$132M$138M$54M$53M$39M$71M$99M$115M
Accounts Payable $2M$2M$4M$2M$5M$1M$1M$3M$3M$1M$2M$1M
Accrued Liabilities $6M$5M$8M·········
Current Liabilities $23M$20M$26M$12M$17M$11M$7M$10M$6M$5M$7M$7M
Capital Leases $2M$2M$719.0K$1M$2M$3M$3M·····
Common Stock $262.0K$248.0K$247.0K$240.0K$239.0K$231.0K$187.0K$164.0K$140.0K$140.0K$138.0K$137.0K
Retained Earnings $-453M$-489M$-475M$-456M$-422M$-388M$-358M$-331M$-308M$-271M$-239M$-219M
AOCI $8.0K$11.0K$2.0K$0····$17.0K$7.0K$421.0K$1M
Stockholders' Equity $103M$55M$66M$78M$107M$120M$38M$37M$29M$64M$90M$106M
Liabilities + Equity $157M$115M$121M$94M$132M$138M$54M$53M$39M$71M$99M$115M
Shares Outstanding 94,553,19189,541,24689,237,46586,624,64386,433,43283,675,85667,922,83659,849,78451,293,07051,131,53450,572,24450,254,492
Cash Flow 10
Metric Trend 202520242023202220212020201920182017201620152014
Stock-based Comp $2M$3M$4M$4M$4M$3M$2M$2M$3M$3M$4M$4M
Operating Cash Flow $32M$50M$-36M$-34M$-23M$-28M$-28M$-13M$-31M$-20M$-26M$-11M
CapEx $306.0K$118.0K$172.0K$477.0K$292.0K$166.0K$155.0K$158.0K$385.0K$3M$3M$2M
Investing Cash Flow $30M$-46M$36M$37M$7M$-82M$5M$-35M$46M$16M$10M$-64M
Stock Issued $11M$544.0K$3M$0$15M$74M$23M$28M···$71M
Net Stock Activity $11M$544.0K$3M$0$15M$74M$23M$28M···$71M
Financing Cash Flow $11M$554.0K$3M$353.0K$17M$108M$26M$28M$201.0K$2M$972.0K$72M
Net Change in Cash $72M$4M$3M$3M$704.0K···$16M$-1M$-14M$-3M
Taxes Paid $55.0K$14M$12.0K······$20.0K·$360.0K
Free Cash Flow $31M$49M$-36M$-35M$-23M$-28M$-28M$-13M$-31M$-22M$-29M$-13M
Profitability 8
Metric Trend 202520242023202220212020201920182017201620152014
Gross Margin 87.3%71.5%94.0%87.0%88.7%97.0%·94.2%·68.7%82.4%73.0%
Operating Margin 43.0%-53.4%-38.8%-471.6%-584.6%-1574.8%·-130.5%·-4576.3%-225.5%-99.8%
Net Margin 48.6%-51.1%-56.0%-449.2%-570.0%-1484.9%·-127.0%·-4425.0%-217.3%-89.7%
Pretax Margin 48.6%-34.8%-29.2%-448.5%-570.0%-1484.9%·-127.0%·-4422.2%-213.1%-86.8%
EBITDA Margin 43.0%-53.4%-38.8%-471.6%-584.6%-1574.8%·-130.5%·-4576.3%-225.5%-99.8%
ROA 26.0%-12.0%-17.4%-29.8%-25.3%-30.9%-51.1%-49.2%-67.5%-37.0%-18.8%-12.9%
ROE 44.8%-23.6%-26.2%-36.5%-30.2%-37.6%-72.4%-67.9%-79.9%-41.1%-20.6%-16.1%
ROIC 30.4%-39.8%-38.0%-45.6%··-73.4%··-51.3%-23.7%-12.0%
Liquidity & Solvency 2
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 6.65.34.47.27.212.36.64.75.013.213.311.4
Quick Ratio 4.42.13.30.90.50.91.30.64.12.02.84.1
Efficiency 2
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 0.50.20.30.10.00.0·0.4·0.00.10.1
Receivables Turnover ·0.91.1··2.0····2.4·
Per Share 5
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share $1.09$0.61$0.73$0.90$1.23$1.43$0.56$0.62$0.57$1.24$1.78$2.11
Revenue / Share $0.78$0.31$0.38$0.09$0.07$0.03·$0.32·$0.01$0.18$0.26
Cash Flow / Share $0.34$0.55$-0.41$-0.40$-0.27$-0.36$-0.44$-0.24$-0.60$-0.39$-0.51$-0.23
Cash / Share $0.96$0.20$0.16$0.13$0.09$0.09$0.14$0.10$0.50$0.19$0.21$0.51
EPS (TTM) $0.38$-0.16$-0.21$-0.39$-0.41$-0.37$-0.43$-0.41$-0.72$-0.62$-0.40$-0.26
Valuation (TTM) 10
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM $73M$28M$33M$8M$6M$2M·$18M·$712.0K$9M$12M
Net Income TTM $35M$-14M$-19M$-34M$-34M$-30M$-27M$-23M$-37M$-32M$-20M$-11M
Market Cap $145M$137M$177M$62M$372M$1.01B$405M$130M$128M$261M$323M$419M
P/E 4.0-9.6-9.4-1.8-10.5-32.7-13.9-5.3-3.5-8.2-16.0-32.0
P/S 2.04.95.38.361.9506.7·7.3·366.334.833.8
P/B 1.42.52.70.83.58.510.63.54.44.13.63.9
P / Tangible Book 1.42.52.70.83.58.5······
P / Cash Flow 4.62.8-4.9-1.8-16.3-35.8-14.5-9.8-4.2-13.2-12.6-37.6
P / FCF 4.62.8-4.9-1.8-16.1-35.6-14.4-9.7-4.1-11.6-11.2-32.1
Earnings Yield 24.8%-10.5%-10.6%-54.2%-9.5%-3.1%-7.2%-18.9%-28.8%-12.2%-6.3%-3.1%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $73M $28M $33M $8M $6M
Gross Margin % 87.3% 71.5% 94.0% 87.0% 88.7%
Operating Margin % 43.0% -53.4% -38.8% -471.6% -584.6%
Net Income $35M $-14M $-19M $-34M $-34M
Diluted EPS $0.38 $-0.16 $-0.21 $-0.39 $-0.41

Institutional owners (13F) 88 filers · $31.3M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 88
Value held $31.3M
New positions 17
Exited positions 11
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
17 (+2 vs prior Q) 11 (+6 vs prior Q) 15 (-2 vs prior Q) 22 (+5 vs prior Q) +72K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
SILVERARC CAPITAL MANAGEMENT, LLC $6,814,310 3,184,257 21.80% Shares
RENAISSANCE TECHNOLOGIES LLC $4,017,850 1,877,500 12.85% Shares
MORGAN STANLEY $2,251,250 1,051,986 7.20% Shares
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $2,183,000 1,020,000 6.98% Shares
Taylor Frigon Capital Management LLC $1,802,267 842,181 5.77% Shares
ARK Investment Management LLC $1,683,187 786,536 5.39% Shares
Altshuler Shaham Ltd $1,119,128 521,625 3.58% Shares
TWO SIGMA INVESTMENTS, LP $1,096,577 512,419 3.51% Shares
STATE STREET CORP $889,530 415,668 2.85% Shares
Atom Investors LP $649,546 303,526 2.08% Shares
Yelin Lapidot Holdings Management Ltd. $603,444 281,983 1.93% Shares
UBS Group AG $589,942 275,674 1.89% Shares
MILLENNIUM MANAGEMENT LLC $560,748 262,032 1.79% Shares
AMERICAN CENTURY COMPANIES INC $457,384 213,731 1.46% Shares
WINTON GROUP Ltd $421,815 197,110 1.35% Shares
TWO SIGMA ADVISERS, LP $380,793 248,884 1.22% Shares
DAFNA Capital Management LLC $360,016 168,232 1.15% Shares
ROTHSCHILD INVESTMENT LLC $300,884 140,600 0.96% Shares
Arax Advisory Partners $282,052 131,800 0.90% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $267,286 124,900 0.86% Put option
XTX Topco Ltd $254,818 119,074 0.82% Shares
Cresset Asset Management, LLC $237,709 111,079 0.76% Shares
CITADEL ADVISORS LLC $221,546 103,526 0.71% Shares
RAYMOND JAMES FINANCIAL INC $205,671 96,108 0.66% Shares
MATRIX ASSET ADVISORS INC/NY $200,803 93,833 0.64% Shares
OSAIC HOLDINGS, INC. $178,442 83,385 0.57% Shares
Kingsview Wealth Management, LLC $178,003 83,179 0.57% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $167,221 78,141 0.54% Shares
EAGLE ROCK INVESTMENT COMPANY, LLC $152,394 71,212 0.49% Shares
SCHNIEDERS CAPITAL MANAGEMENT LLC $149,904 90,000 0.48% Shares
GOLDMAN SACHS GROUP INC $127,875 59,755 0.41% Shares
EWA, LLC $127,101 59,393 0.41% Shares
GEODE CAPITAL MANAGEMENT, LLC $121,419 56,738 0.39% Shares
Platform Technology Partners $117,700 55,000 0.38% Shares
STIFEL FINANCIAL CORP $115,835 54,129 0.37% Shares
Squarepoint Ops LLC $109,825 51,320 0.35% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $108,712 50,800 0.35% Call option
SCHNIEDERS CAPITAL MANAGEMENT, LLC. $107,000 50,000 0.34% Shares
CITADEL ADVISORS LLC $106,144 49,600 0.34% Call option
JANE STREET GROUP, LLC $105,515 49,306 0.34% Shares
SIH Partners, LLLP $91,132 42,585 0.29% Shares
Invesco Ltd. $85,634 40,016 0.27% Shares
IEQ CAPITAL, LLC $85,600 40,000 0.27% Shares
Secure Asset Management, LLC $85,600 40,000 0.27% Shares
Sullivan Wood Capital Management LLC $74,900 35,000 0.24% Shares
GLENMEDE TRUST CO NA $73,830 34,500 0.24% Shares
Graham Capital Management, L.P. $71,472 33,398 0.23% Shares
Stonepine Capital Management, LLC $67,168 31,387 0.21% Shares
Calamos Wealth Management LLC $63,130 29,500 0.20% Shares
Quadrature Capital Ltd $63,072 29,473 0.20% Shares

Show all 88 institutional owners →

Activists & 5%+ owners 7 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
SS OR IRS IDENTIFICATION NO. OF ABOVE PERSON Martin S. Gerstel 2) May 26, 2010 · Initial filing Passive investment SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person July 20, 2009 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person July 1, 2009 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person May 14, 2009 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person March 30, 2009 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person July 31, 2008 · Initial filing Passive investment SEC
Clal Biotechnology Industries Ltd. (no U.S. I.D. number), Clal Industries and Investments Ltd. (no U.S. I.D. number), IDB Development Corporation Ltd. (no U.S. I.D. number), IDB Holding Corporation Ltd. (no U.S. I.D. number), Nochi Dankner, Shelly Dankner-Bergman, Avraham Livnat, Ruth Manor July 7, 2003 · Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 12 insiders · 6 officers · 7 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Eran Ophir President and CEO July 29, 2026 A 11,375 0 3 $-42,931
David Silberman Chief Financial Officer July 29, 2026 A 55,000 0 0 $0
Pierre Ferre Chief Operating Officer July 29, 2026 A · 0 0 $0
Russo Sharon Kredo SVP, Research & Discovery July 29, 2026 A 37,500 0 0 $0
Michelle Mahler Chief Medical Officer July 29, 2026 A 36,625 0 0 $0
Zurit Levine SVP, Business Development July 29, 2026 A 47,375 0 9 $-83,371
Eran Perry Director July 29, 2026 A 17,500 0 0 $0
Gilead Halevy Director July 29, 2026 A 18,907 0 0 $0
Savitzky Kinneret Livnat Director July 29, 2026 A 20,850 0 0 $0
Mathias Hukkelhoven Director July 29, 2026 A 17,500 0 0 $0
Anat Cohen-Dayag Director July 29, 2026 A · 0 0 $0
Sanford S Zweifach Director July 29, 2026 A 20,180 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 1 ETF

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
QQQS · Invesco Exchange-Traded Fund Trust … 0.48% 46,858 SH Oct. 1, 2026 Daily

CGEN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 11 analysts BUY
Median target $4.00 +73.2%
5 45.5% Strong Buy
5 45.5% Buy
1 9.1% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

5 analysts · 2026-10-03

Mean target $4.60 +99.1%

← Below all targets Current price $2.31
Low$4.00 Mean$4.60 High$6.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
CGEN $145M 4.0 · 48.6% 44.8% 87.3%
URGN $1.13B · 21.4% -139.8% 154.4% 88.7%
ENTX $90M 7.8 -76.8% -27235.7% -75.4% 0.00%
KMDA · 20.2 · 11.2% 7.6% 42.3%

Latest News Recent headlines mentioning this company

23

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 20-F filed Mar 2, 2026